Review
doi: 10.1111/j.0007-0963.2004.05903.x.
Fumaric acid esters, their place in the treatment of psoriasis
Affiliations
- PMID: 15099356
- DOI: 10.1111/j.0007-0963.2004.05903.x
Item in Clipboard
Review
Fumaric acid esters, their place in the treatment of psoriasis
Br J Dermatol.
2004 Apr.
No abstract available
Comment on
-
Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.Br J Dermatol. 2003 Aug;149(2):363-9. doi: 10.1046/j.1365-2133.2003.05433.x. Br J Dermatol. 2003. PMID: 12932244
Similar articles
-
Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience.Clin Exp Dermatol. 2012 Oct;37(7):793-5. doi: 10.1111/j.1365-2230.2012.04351.x. Epub 2012 Apr 30. Clin Exp Dermatol. 2012. PMID: 22548419 No abstract available.
-
Fumaric acid esters in the treatment of psoriasis.Br J Dermatol. 2010 Feb;162(2):237-8. doi: 10.1111/j.1365-2133.2009.09624.x. Br J Dermatol. 2010. PMID: 20374246 No abstract available.
-
[Immunomodulation with fumaric acid. Systemic therapy in psoriasis].Orv Hetil. 2000 Jan 16;141(3):129-32. Orv Hetil. 2000. PMID: 10693335 Review. Hungarian.
-
[15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris].J Dtsch Dermatol Ges. 2009 Apr;7 Suppl 2:S3-16. doi: 10.1111/j.1610-0387.2009.07059.x. J Dtsch Dermatol Ges. 2009. PMID: 19522921 Review. German. No abstract available.
-
Fumaric acid esters in psoriasis.Br J Dermatol. 2006 Mar;154(3):567-8. doi: 10.1111/j.1365-2133.2005.07103.x. Br J Dermatol. 2006. PMID: 16445802 No abstract available.
Cited by
-
Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study.J Clin Aesthet Dermatol. 2022 Jan;15(1):53-58. J Clin Aesthet Dermatol. 2022. PMID: 35309277 Free PMC article.
-
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.Drug Des Devel Ther. 2014 May 19;8:555-68. doi: 10.2147/DDDT.S52428. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24876766 Free PMC article. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2023 Jul 12;7:CD011535. doi: 10.1002/14651858.CD011535.pub6. PMID: 35603936 Free PMC article. Updated.
-
Adenylosuccinic Acid Is a Non-Toxic Small Molecule In Vitro and In Vivo.Pharmaceuticals (Basel). 2023 Oct 13;16(10):1458. doi: 10.3390/ph16101458. Pharmaceuticals (Basel). 2023. PMID: 37895929 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
